Notice Type
Notice Title

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:


Active Ingredient:
Dosage Form:
New Zealand Sponsor:

Fibrinogen 900mg – 1300mg
Powder for injection with diluent
CSL Behring (NZ) Limited
CSL Behring GmbH, Marburg, Germany

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 1st day of February 2019.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).